After investing $4.4 million in 2007 in 23andMe, a genetic screening company, Google just invested in a new DNA screening startup called Navigenics.
Much in the way it invested in 23andMe, Google wants to plant an early stake in a potentially large new market around genetic data. “We are interested in supporting companies and making investments in companies that [bolster] our mission statement, which is organizing the world’s information and making it universally accessible and useful,” Google spokesman Andrew Pederson says.
Although I am still not sure where they are going with this, it reinforces my fear of what Google is preparing for the future.
Read the full article here.